Discover trends, market shifts, and competitive outlooks for the cardiac marker testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Current and Projected Market Size of the Cardiac Marker Testing Market Through 2034?

The market size for cardiac marker testing has experienced a swift expansion in the last few years. The market, which is set to increase from $6.52 billion in 2024 to $7.19 billion in 2025, boasts a compound annual growth rate (CAGR) of 10.3%. The notable growth observed in the historic period is linked to factors such as an aging population, enhancement in educational campaigns, heightened awareness, development in healthcare facilities, and an increase in patient numbers.

In the coming years, the cardiac marker testing market is anticipated to experience significant expansion. The market is projected to reach $10.56 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.1%. The growth during this period can be credited to a rise in cardiovascular disease cases, an uptick in strategic alliances and partnerships, amplified research and development initiatives, favorable insurance reimbursement policies, and increased demand for point-of-care (POC) testing. The forecast period will witness key trends such as advanced diagnostic technologies, automated analyzers, innovative cardiac marker testing assays, advancements in digital health technologies, and the introduction of integrative technologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19358&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Cardiac Marker Testing Market?

The cardiac marker testing market’s growth is predicted to be fueled by the increasing prevalence of cardiovascular diseases. These diseases encompass various disorders influencing the heart and blood vessels, including ailments like coronary artery disease, stroke, and heart failure. The surge in cardiovascular illnesses is primarily due to factors like unhealthy eating habits, lack of physical activity, cigarette smoking, immoderate alcohol consumption, and air contamination. To diagnose accurately, verify severity, and monitor the progression or response to treatment of cardiac conditions, cardiac marker testing is essential. It identifies precise biomarkers released during myocardial damage. For example, the American Heart Association, a nonprofit organization based in the US, reported in January 2024 that the age-considered death rate from cardiovascular disease elevated to 233.3 per 100,000, a rise of 4.0% from 224.4 per 100,000 compared to 2023. In 2021, 20,114 deaths in the U.S were attributed to sudden cardiac arrest. As a result of these factors, the increased occurrence of cardiovascular conditions is propelling the cardiac marker testing market.

Which Primary Segments of the Cardiac Marker Testing Market Are Driving Growth and Industry Transformations?

The cardiac marker testingmarket covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments

2) By Biomarker Type: Troponin I And T, Creatine Kinase-MB (CK-MB), Natriuretic Peptide, Myoglobin, High-Sensitivity C-Reactive Protein, Other Cardiac Biomarkers

3) By Application: Laboratory Testing Facilities, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:

1) By Reagents and Kits: Troponin Test Kits, B-type Natriuretic Peptide (BNP) Test Kits, Creatine Kinase-MB (CK-MB) Test Kits, Myoglobin Test Kits, Other Cardiac Biomarker Reagents

2) By Instruments: Point-of-Care Testing Devices, Automated Analyzers, Immunoassay Systems, Portable Diagnostic Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=19358&type=smp

Which Regions Are Key Players in the Growth of the Cardiac Marker Testing Market?

North America was the largest region in the cardiac marker testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac marker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Cardiac Marker Testing Market?

The leading players in the cardiac marker testing market are concentrating their efforts on creating highly advanced products including cardiac assays. These assays deliver valuable and accurate information regarding cardiac health. They are diagnostic assessments that measure biomarkers or other indicators in samples such as blood, to evaluate heart functions, identify cardiovascular diseases, or determine the risk of heart-related conditions. For example, Mindray, a medical device firm based in China, introduced troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers in October 2023. The hs-cTnI assay stands out for its extraordinary sensitivity, precision, and reliability, exceeding the minimum standards by achieving a 93% detection rate between the limit of detection (LoD) and the 99th percentile upper reference limit (URL). It also maintains an imprecision coefficient of variation (CV) below 5% at the 99th URL, proving its high efficacy in detecting myocardial injury. Mindray’s NT-proBNP assay, a crucial cardiac marker for heart failure, demonstrates high precision with a coefficient of variation (CV) of =5%. It also effectively reduces interference from 55 common heart disease drugs, ensuring accurate detection and management of heart failure.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cardiac-marker-testing-global-market-report

What Parameters Are Used to Define the Cardiac Marker Testing Market?

Cardiac marker testing refers to a series of diagnostic tests used to measure specific substances in the blood that can indicate damage or stress to the heart. These markers are often proteins or enzymes released into the bloodstream when the heart muscle is injured. Cardiac marker tests are crucial for diagnosing and evaluating conditions such as myocardial infarction (heart attack), heart failure, and other cardiac diseases.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19358

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model